Frontier Biotech is a research-based, clinical stage pharmaceutical company founded in 2002. The management team have extensive business and development experiences in the US and China pharma/biotech industry. Frontier Biotech leverages China's large patient population, and rapid growing economy and pharmaceutical market, develops innovative pharmaceutical products with worldwide IP protection. Frontier Biotech develops Albuvirtide, the first long-acting anti-HIV drug worldwide, which has been approved by CFDA and launched in the third quarter of 2018. The company is dedicated in the discovery, development and commercialization of innovative therapeutic products for unmet medical needs and under-served patients.
more